Heparin Market Size was estimated at USD 7.5 billion in 2022 and is poised to reach at 9.20 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 2.6% for the forecast period of 2023-2030.
The Heparin market is expected to witness significant growth in the coming years. Heparin, a naturally occurring anticoagulant, is widely used in various medical applications such as surgeries, dialysis, and treatment of deep vein thrombosis. The increasing prevalence of cardiovascular diseases and the growing aging population are major factors driving the demand for heparin.
One of the key drivers for the growth of the heparin market is the rising incidence of venous thromboembolism (VTE) worldwide. VTE includes conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE), which can be life-threatening if not treated promptly. Heparin plays a crucial role in preventing and treating these conditions, thereby fueling its demand.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2975
Moreover, advancements in healthcare infrastructure and increasing healthcare expenditure are also contributing to market growth. The availability of improved diagnostic techniques and surgical procedures has led to a higher demand for heparin during surgeries and other medical interventions.
KEY MARKET SEGMENTS
By Type
- Low Molecular Weight Heparin
- Ultra-low Molecular Weight Heparin
- Unfractionated Heparin
By Route of Administration
- Intravenous
- Subcutaneous
By Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
By End-use
- Outpatient
- Inpatient
By Source
- Porcine
- Bovine
- Others
Major Players Listed in the Report are as Follows:
Pfizer Inc., Techdow USA Inc., Hepalink Group,LEO Pharma A/S, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Sanofi, Aspen Holdings, Fresenius SE & Co. KGaA, B. Braun Medical, Inc., Sandoz (Novartis AG), Hebei Changshan Biochemical Pharmaceutical Co, Ltd, and others.
Other Report
Autoimmune Disease Testing Market Growth
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
